The role of fibronectin in BRAF-mutant thyroid cancer treatment
New research overseen by University of Colorado Cancer Center (USA) member Rebecca Schweppe, PhD, could…
Browsing: papillary thyroid cancer
Paediatric cancer drug shows 93 percent response rate
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective…